Trump panel urges more treatment options to fight opioid crisis

Published 11/01/2017, 05:00 PM
Updated 11/01/2017, 05:10 PM
© Reuters. A needle used for shooting heroin litters the ground on a sidewalk in the Kensington section of Philadelphia

By Toni Clarke

(Reuters) - A panel convened by U.S. President Donald Trump to tackle the opioid crisis called on Wednesday for more treatment programs, tighter prescribing guidelines and additional drug courts to help reduce overdose deaths.

The commission, led by New Jersey Governor Chris Christie, said the recommendations would require funding by Congress but did not recommend an amount. Trump last week declared the opioid crisis a public health emergency.

Public health experts broadly welcomed the proposed measures.

"This sounds to me like a very progressive and very needed move," said Professor Kosali Simon, a health economist at Indiana University, of the recommendations.

But Paul Hanly, a New York lawyer representing local governments in a legal battle against opioid makers, said recommendations, while laudable, would be "toothless" without substantial funding.

Opioids include prescription painkillers, heroin and fentanyl. More than 100 Americans die daily from overdoses, according to federal data.

The commission recommended a national media campaign to encourage opioid addicts to seek help. Only 10.6 percent of people who need treatment get it, the report noted.

The media campaign would encourage addicts to "stop being afraid or ashamed of seeking help when facing their addiction."

It urged expansion of drug courts, in which addicts convicted of non-violent offenses are diverted into programs that combine treatment with mandatory drug testing and court appearances.

The commission said drug courts, which are currently offered in just 44 percent of U.S. counties, should embrace medication-assisted treatment to improve outcomes.

The U.S. Food and Drug Administration last week announced plans to encourage wider use of substitute opioids such as methadone and buprenorphine, which do not induce a high and are used to help people through drug addiction recovery.

Still, Dr. Stefan Kertesz of the University of Alabama at Birmingham said communities often lack treatment facilities where drug courts can send addicts. And many drug courts charge fees that make them unaffordable for many.

"Drug courts often function as pay to play," Kertesz said. "Only people who can come up with money can escape a prison sentence."

The report recommended expanding the ranks of emergency responders allowed to administer naloxone to treat overdoses. It also encouraged stricter prescribing guidelines for physicians.

© Reuters. A needle used for shooting heroin litters the ground on a sidewalk in the Kensington section of Philadelphia

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.